Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand

  1. Home

  • Monday, Nov 13th
    9:00 AM - 10:00 AM PT
    13M114: Calcinosis in Juvenile Dermatomyositis
    Location: Room 7A-B
    Moderator: Adam Huber, MD, MSc – IWK Health Centre
    Moderator: Jessica Neely, MD – UCSF
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
     CME: 1 hours
  • Monday, Nov 13th
    9:00 AM - 9:15 AM PT
    Pathogenesis of Calcinosis in Juvenile Dermatomyositis
    Location: Room 7A-B
    Speaker: Christian Lood, PhD – University of Washington
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:15 AM - 9:20 AM PT
    Q&A
    Location: Room 7A-B
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:20 AM - 9:35 AM PT
    Assessment of Calcinosis in Juvenile Dermatomyositis
    Location: Room 7A-B
    Speaker: Adam Schiffenbauer, MD – NATIONAL INSTITUTES OF HEALTH
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:35 AM - 9:40 AM PT
    Q&A
    Location: Room 7A-B
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:40 AM - 9:55 AM PT
    Treatment of Calcinosis in Juvenile Dermatomyositis
    Location: Room 7A-B
    Speaker: Clarissa Pilkington, MBBS, BSc, FRCPC, FRCP – Great Ormond Street Hospital
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:55 AM - 10:00 AM PT
    Q&A
    Location: Room 7A-B
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    (1221–1255) Pediatric Rheumatology – Clinical Poster II: Connective Tissue Disease
    Location: Poster Hall
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1221: Familial Clustering of Dysbiotic Oral and Fecal Microbiomes in Juvenile Dermatomyositis (JDM)
    Location: Poster Hall
    Abstract Poster Presenter: Albert Chow, MD (he/him/his) – Loma Linda University
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1222: The Association Between Gingival Inflammation and Clinical Signs of Active Juvenile Dermatomyositis (JDM)
    Location: Poster Hall
    Abstract Poster Presenter: Albert Chow, MD (he/him/his) – Loma Linda University
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1223: Extracorporeal Life Support for Childhood-Onset Systemic Lupus Erythematosus: An ELSO Registry Analysis
    Location: Poster Hall
    Abstract Poster Presenter: Carla Levin, MD, MS – Baylor College of Medicine
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1224: Mental Health Screening Follow-Up in the Childhood-Onset Systemic Lupus Clinic
    Location: Poster Hall
    Abstract Poster Presenter: Audrea Chen, MD, FRCPC – The Hospital for Sick Children
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1225: Nailfold Video Capillaroscopy and Its Association with Autoantibodies and Rheumatic Diseases in Pediatric Patients
    Location: Poster Hall
    Abstract Poster Presenter: Antonia Valenzuela, MD, MS – Pontificia Universidad Catolica de Chile
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1226: Examining the Relationship Between Socioenvironmental Factors and Cognitive Functioning in Youth with Childhood-Onset Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Andrea Knight, MD, MSCE – Hospital for Sick Children
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1227: Serious Infections Following Rituximab Administration in Children with Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Jordan Roberts, MD, MPH – Seattle Children's Hospital
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1228: Validation of the PEDiatric Behçet's Disease Classification Criteria (PEDBD): An International Consensus-based Approach
    Location: Poster Hall
    Abstract Poster Presenter: Isabelle Kone Paut, MD – APHP, Bicetre hospital, university of Paris Saclay
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1229: Longitudinal Assessment of Self-reported Executive Function in Youth with Childhood-Onset Lupus
    Location: Poster Hall
    Abstract Poster Presenter: Justine Ledochowski, PhD – The Hospital for Sick Children
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1230: Differences in Nailfold Capillary Morphology Distinguish Juvenile Dermatomyositis Patients That Are Myositis-Specific Autoantibody Positive
    Location: Poster Hall
    Abstract Poster Presenter: Nicholas McClellan, DO – University of Michigan
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1231: Successful Implementation of a Mental Health Screening Program for Youth with Juvenile Dermatomyositis
    Location: Poster Hall
    Abstract Poster Presenter: Andrea Knight, MD, MSCE – Hospital for Sick Children
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1232: Improvement Across Organ System, Physician and Patient Reported Outcome Measures over a 36-time Period in the Juvenile Systemic Scleroderma Inception Cohort
    Location: Poster Hall
    Abstract Poster Presenter: Ivan Foeldvari, MD (he/him/his) – Hamburger Zentrum für Kinder- und Jugendrheumatologie
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1233: The Pattern of Medication Use Significantly Changed over 36 Months Observation Period. Result from the Juvenile Scleroderma Inception Cohort
    Location: Poster Hall
    Abstract Poster Presenter: Ivan Foeldvari, MD (he/him/his) – Hamburger Zentrum für Kinder- und Jugendrheumatologie
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1234: Cognitive Performance Score of the Pediatric Automated Neuropsychological Assessment Metrics Software in a Brazilian Cohort and Its Association with Disease Activity
    Location: Poster Hall
    Abstract Poster Presenter: Simone Appenzeller, MD, PhD – Unicamp
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1235: Apparent Diffusion Coefficient (ADC) from Diffusion Weighted Imaging (DWI) as an Objective Tool to Differentiate Normal Maturational Subchondral Signal from Inflammation at the Sacroiliac Joint in Youth
    Location: Poster Hall
    Abstract Poster Presenter: Pamela Weiss, MD – Childrens Hospital of Philadelphia
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1236: Melanoma Differentiation-Associated Protein-5 in Juvenile Dermatomyositis: A Single Center Cohort
    Location: Poster Hall
    Abstract Poster Presenter: Dawn Gist, MD – Baylor College of Medicine Pediatrics Residency
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1237: The Associations Between Depressive Symptoms and Executive Function and Academic Outcomes in Children with SLE
    Location: Poster Hall
    Abstract Poster Presenter: Hannah Bradfield, DO – Baylor College of Medicine
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1238: Prevalence of Celiac Disease Among Children and Adolescents with Systemic Lupus Erythematosus (SLE)
    Location: Poster Hall
    Abstract Poster Presenter: Oscar Mwizerwa, MBBS, MMed (he/him/his) – University of Toronto, The Hospital for Sick Children
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1239: Clinical Manifestations and Management of Takayasu Arteritis: A Multicenter Pediatric Cohort
    Location: Poster Hall
    Abstract Poster Presenter: Ana Luiza Altaffer, MD (she/her/hers) – Baylor College of Medicine
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1240: Obvious Only in Retrospect: A Cohort of STING Associated Vasculopathy in Infancy (SAVI) Without Typical Rash
    Location: Poster Hall
    Abstract Poster Presenter: Ilaria Maccora, MD (she/her/hers) – ​PhD student, in the Area of Drugs and Innovative Treatments, NeuroFARBA Department, University of Florence. Meyer Children's Hospital, Florence Italy
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1241: Adverse Childhood Experiences in a Paediatric Systemic Lupus Erythematosus Cohort
    Location: Poster Hall
    Abstract Poster Presenter: Andrea Knight, MD, MSCE – Hospital for Sick Children
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1242: Agreement Between Parent- and Self-Report of Executive Function in Adolescents with Childhood-Onset Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Justine Ledochowski, PhD – The Hospital for Sick Children
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1244: Characterizing Lupus in African American Children in Southern United States
    Location: Poster Hall
    Abstract Poster Presenter: Anita Dhanrajani, MBBS, MSc (she/her/hers) – Children's Hospital of New Orleans
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1245: Evaluating a Diagnostic Algorithm for Childhood Sjögren’s Disease
    Location: Poster Hall
    Abstract Poster Presenter: Sara Stern, MD (she/her/hers) – University of Utah
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1246: Assessment and Outcomes of 63 Cases of Juvenile Dermatomyositis-Associated Calcinosis
    Location: Poster Hall
    Abstract Poster Presenter: Belina Yi, DO (she/her/hers) – The Johns Hopkins University School of Medicine
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1247: Pharmacokinetic, Pharmacodynamic, and Safety Profile of Subcutaneous Belimumab in Pediatric Patients with Systemic Lupus Erythematosus: Analysis of Data from a Multicenter, Open-Label Trial
    Location: Poster Hall
    Abstract Poster Presenter: Hermine Brunner, MD, MSc, MBA – Cincinnati Children's Hospital Medical Center
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1248: Thrombotic Manifestations in Pediatric Behçet Disease Patients: A Multicentre Comparative Study from EUROFEVER Registry
    Location: Poster Hall
    Abstract Poster Presenter: Maria Vincenza Mastrolia, MD – NEUROFARBA Department, University of Florence
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1249: Cross-Sectional Associations of Emotional Distress and Cardiovascular Health in Juvenile Lupus and Dermatomyositis
    Location: Poster Hall
    Abstract Poster Presenter: Kaveh Ardalan, MD, MS – Duke University School of Medicine
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1250: Local Inflammatory Response Mediated by the Homing of Tfh17 Cells Is Involved in Tissue Injury of Immunoglobulin a Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: Xiaoxue Ma – The First Hospital of China Medical University
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1251: Neurologic Manifestations of Pediatric Sjogren's Disease Patients: Case Series from an Academic Children’s Hospital
    Location: Poster Hall
    Abstract Poster Presenter: Maya Faison, MD (she/her/hers) – University of Chicago Medicine
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1252: Physician Global Assessment of Disease Activity in Childhood-Onset Systemic Lupus Erythematosus – Does the Approach Matter?
    Location: Poster Hall
    Abstract Poster Presenter: Ekemini Ogbu, MD, MSc – Cincinnati Children's Hospital Medical Center
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1253: The Novel Florida Scoring System: A Machine Learning-Based Stratification of Clinical and Laboratory Features in Children with Suspected Sjögren’s Disease
    Location: Poster Hall
    Abstract Poster Presenter: Akaluck Thatayatikom, MD, RhMSUS – AdventHealth for Children
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1254: Outcome of Pediatric Lupus in South Asia: Data from Indian SLE Inception Cohort for Research (INSPIRE)
    Location: Poster Hall
    Abstract Poster Presenter: Amita Aggarwal, MD, MBBS, DM – Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    9:00 AM - 11:00 AM PT
    1255: Clinical Characteristics and Disease Outcomes of anti-NXP2 Positive Juvenile Dermatomyositis: A Single Center Cohort
    Location: Poster Hall
    Abstract Poster Presenter: Sarah Molina, MD (she/her/hers) – Baylor College of Medicine - Pediatrics Residency Program
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    2:00 PM - 3:30 PM PT
    13M147: Abstracts: Pediatric Rheumatology – Clinical II: Connective Tissue Disease (1621–1626)
    Location: Room 7A-B
    Abstract Moderator: Eyal Muscal, MD, MS – Baylor College of Medicine
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    2:00 PM - 2:10 PM PT
    1621: Maxillofacial MRI Augments Detection of Non-CNS Abnormalities in Pediatric Craniofacial Scleroderma
    Location: Room 7A-B
    Presenting Author: Daniel Glaser, MD (he/him/his) – Yale University School of Medicine
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    2:15 PM - 2:25 PM PT
    1622: Myositis-associated Autoantibodies in Juvenile Myositis Are Associated with Severe Disease Features and Mortality
    Location: Room 7A-B
    Presenting Author: Matthew Sherman, MD, MHS – DAIT/NIAID/NIH
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    2:30 PM - 2:40 PM PT
    1623: Diffuse Juvenile Systemic Sclerosis Patients Show Distinct Organ Involvement, Antibody Pattern and Have More Severe Disease in the Largest jSSc Cohort of the World. Results from the Juvenile Scleroderma Inception Cohort
    Location: Room 7A-B
    Presenting Author: Ivan Foeldvari, MD (he/him/his) – Hamburger Zentrum für Kinder- und Jugendrheumatologie
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    2:45 PM - 2:55 PM PT
    1624: Racial Disparities Impact Achieving LLDAS and Glucocorticoid Use in Pediatric Lupus: A CARRA Registry Study
    Location: Room 7A-B
    Presenting Author: William Soulsby, III, MD – University of California, San Francisco
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    3:00 PM - 3:10 PM PT
    1625: Identifying Potential Neuroimaging Biomarkers of Neuropsychiatric Lupus in Children Using Deep Learning
    Location: Room 7A-B
    Presenting Author: Santiago Arciniegas, MSc – The Hospital for Sick Children
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    3:15 PM - 3:25 PM PT
    1626: Clinical Presentation, Disease Course and 12-month Outcomes in Childhood Polyarteritis Nodosa: A PedVas Study
    Location: Room 7A-B
    Presenting Author: Shamma Alzaabi, MBBS (she/her/hers) – BC Children's hospital
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    4:00 PM - 4:10 PM PT
    1657: Mapping the Network of Coordinated Immune Dysregulation in Juvenile Dermatomyositis at Single-cell Resolution
    Location: Room 7A-B
    Presenting Author: Gabrielle Rabadam, PhD – University of California San Francisco
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    4:45 PM - 4:55 PM PT
    1660: Still’s Disease Patients with High Interferon-stimulated Gene Expression Have Enrichment of Rare, de Novo and Recessive Protein Altering Variants in Innate Immune Pathways
    Location: Room 7A-B
    Presenting Author: Michael Ombrello, MD – National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    5:00 PM - 5:10 PM PT
    1661: Spatial Transcriptional Alterations in the Cellular Landscape of Pediatric Scleroderma Skin
    Location: Room 7A-B
    Presenting Author: Kathryn Torok, MD – University of Pittsburgh
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Monday, Nov 13th
    5:15 PM - 5:25 PM PT
    1662: Chronic Excess IL-18 Induces NK Deficiency, but Drives Hyperinflammation via CD8 T-cell Cytokine Overproduction and Selective Immunodeficiency
    Location: Room 7A-B
    Presenting Author: Scott Canna, MD – Children's Hospital of Philadelphia
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    (2039–2060) Pediatric Rheumatology – Clinical Poster III: Potpourri
    Location: Poster Hall
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    L06: Improvement in Clinical and Patient-Reported Outcomes for Refractory Juvenile-Onset Systemic Sclerosis (jSSc) 6 Months to 2 Years After Autologous Stem Cell Transplantation (ASCT)
    Location: Poster Hall
    Late-Breaking Poster Presenter: Kathryn Torok, MD – University of Pittsburgh
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    1705: Reduced DNASE1L3 Activity and Increased Anti-NET Protective Antibodies Contributes to Accumulation of Neutrophil Extracellular Traps in Pediatric SLE Patients
    Location: Poster Hall
    Abstract Poster Presenter: Bharati Matta, MS – The Feinstein Institutes for Medical Research
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    1708: In Cis SOCS1 Variants Illustrate the Precise Regulation of Interferon Signaling Needed to Prevent Autoimmunity
    Location: Poster Hall
    Abstract Poster Presenter: Yan Du, MD, PhD – Harvard medical school
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    1709: Tape Stripping Expression Signatures Identify Biologically Unique Juvenile Dermatomyositis Patient Subgroup Characterized by Increased Mitochondrial Dysfunction
    Location: Poster Hall
    Abstract Poster Presenter: Jessica Turnier, MD, MS – University of Michigan
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    1711: CD14+ Monocytes Demonstrate a Unique Transcriptional Signature in Macrophage Activation Syndrome, Highlighting a Role for Interferons and Identifying Putative Hemophagocytes in Circulation
    Location: Poster Hall
    Abstract Poster Presenter: Susan Canny, MD, PhD – Seattle Children's Hospital/University of Washington
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    1712: Identification and Functional Characterization of Eight CANDLE/PRAAS Causing Proteasome Variants in Five Unrelated Patients
    Location: Poster Hall
    Abstract Poster Presenter: Adriana A. Almeida de Jesus, MD, PhD – NIAID, NIH
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    2040: Distinguishing Multisystem Inflammatory Syndrome in Children from Typhus Using Artificial Intelligence: MISC vs. Endemic Typhus (AI-MET)
    Location: Poster Hall
    Abstract Poster Presenter: Angela Chun, MD, MEd – Feinberg School of Medicine, Northwestern University
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    2041: An Analysis of Recurrent Parotitis Patients Referred to Rheumatology Clinic
    Location: Poster Hall
    Abstract Poster Presenter: Yiressy Pina, MD – Baylor College of Medicine
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    2042: Intraocular Cytokine Profiling of Autoimmune Uveitis
    Location: Poster Hall
    Abstract Poster Presenter: Maryrose Hahn, BS – Boston Children's Hospital
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    2043: Phenotype of Musculoskeletal Manifestations in a Canadian Inception Cohort of Pediatric Patients with Inflammatory Bowel Disease
    Location: Poster Hall
    Abstract Poster Presenter: Roberta A Berard, MD, MSc – London Health Sciences Centre
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    2044: Monogenic Interferon Mediated Diseases: Novel Phenotype and Genotype Characteristics from Saudi Population
    Location: Poster Hall
    Abstract Poster Presenter: Alhanouf Alsaleem, MD, MBBS – KFSH&RC
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    2045: Treatment Response in a Cohort of Pediatric Patients with Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy (ADNIV)
    Location: Poster Hall
    Abstract Poster Presenter: Ilaria Maccora, MD (she/her/hers) – ​PhD student, in the Area of Drugs and Innovative Treatments, NeuroFARBA Department, University of Florence. Meyer Children's Hospital, Florence Italy
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    2046: Implementation of an Automated Transition Readiness Assessment in a Pediatric Rheumatology Clinic
    Location: Poster Hall
    Abstract Poster Presenter: Elizabeth Murray, MD – Nationwide Children's Hospital/The Ohio State University
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    2047: Safety of Baricitinib for COVID-19 Related Hyperinflammation in Pediatric Patients: A Large Tertiary Care Center Experience
    Location: Poster Hall
    Abstract Poster Presenter: Meredith Rae, MD (she/her/hers) – Baylor College of Medicine/Texas Children's
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    2048: Development and Usability Testing of Web-based Standardized Scoring Tool for Magnetic Resonance Images from Children with Chronic Nonbacterial Osteomyelitis (CNO)
    Location: Poster Hall
    Abstract Poster Presenter: Farzana Nuruzzaman, MD (she/her/hers) – Stony Brook Children's Hospital
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    2049: Vaccination Coverage and Caregiver Perspectives for Children with Rheumatic Diseases Compared to Healthy Controls
    Location: Poster Hall
    Abstract Poster Presenter: Shine Vazhappilly, MD – Mercy Health - The Jewish Hospital
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    2050: Variability in Vaccination Practices in Children with Rheumatic Diseases: Results of a Rheumatology Provider Childhood Arthritis and Rheumatology Research Alliance (CARRA)-wide Survey
    Location: Poster Hall
    Abstract Poster Presenter: Randal De Souza, MD (he/him/his) – Nationwide Children's Hospital
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    2051: Screening Multisystem Inflammatory Syndrome in Children: Accuracy of SickKids Screening Pathway Compared to ACR Algorithm
    Location: Poster Hall
    Abstract Poster Presenter: Greta Mastrangelo, MD – The Hospital for Sick Children
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    2052: Risk Factors for Hospitalization for SARS-CoV-2 in Pediatric Patients with Rheumatic Diseases: A Systematic Review and Meta-analysis
    Location: Poster Hall
    Abstract Poster Presenter: Qianzi Zhao, MD, PhD – Trinity Health Ann Arbor
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    2053: Predictive Factors Associated with Treatment Response in Chronic Nonbacterial Osteomyelitis
    Location: Poster Hall
    Abstract Poster Presenter: Katherine Nowicki, MD (she/her/hers) – University of Colorado
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    2054: Superiority of Adalimumab in Treating Childhood Chronic Idiopathic Uveitis: Evidence from a Multicentre Experience
    Location: Poster Hall
    Abstract Poster Presenter: Ilaria Maccora, MD (she/her/hers) – ​PhD student, in the Area of Drugs and Innovative Treatments, NeuroFARBA Department, University of Florence. Meyer Children's Hospital, Florence Italy
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    2055: A Randomized Controlled Trial of Two Hepatitis a Vaccine Doses Among Adolescents with Juvenile Idiopathic Arthritis and Crohn's Disease on Immunosuppressive Therapy: A Pilot Study
    Location: Poster Hall
    Abstract Poster Presenter: Racheal Githumbi, MS, BS – University of Calgary
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    2056: Pediatric Acute-onset Neuropsychiatric Syndrome: Markers of Inflammation/autoimmunity at Clinical Presentation and Eventual Development of Arthritis and Other Autoimmune Diseases
    Location: Poster Hall
    Abstract Poster Presenter: Meiqian Ma, MD – Stanford University Medical Center
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    2057: Medical Trauma and Its Association with Pain and Disability Risk in Children with Inflammatory Arthritis
    Location: Poster Hall
    Abstract Poster Presenter: Leah Medrano, MD (she/her/hers) – UCLA Mattel Children's Hospital
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    2058: IL-1 Blocking Treatment Slows the Progression of Sensorineural Hearing Loss in Patients with NOMID
    Location: Poster Hall
    Abstract Poster Presenter: Sara Alehashemi, MD, MPH – NIH/NIAID/TADS
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    2059: Management of Iatrogenic, Recombinant Interleukin-1 Receptor Antagonist-type Amyloidosis on NOMID in Patients on Anakinra
    Location: Poster Hall
    Abstract Poster Presenter: Sara Alehashemi, MD, MPH – NIH/NIAID/TADS
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    9:00 AM - 11:00 AM PT
    2060: Creation of a Standardized and Collaborative Transfer Process from Pediatric to Adult Rheumatology
    Location: Poster Hall
    Abstract Poster Presenter: Alana Haussmann, MD (she/her/hers) – University of California Los Angeles
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    2:00 PM - 3:30 PM PT
    14T154: Abstracts: Pediatric Rheumatology – Clinical III: Potpourri (2473–2478)
    Location: Room 7A-B
    Abstract Moderator: Sheila Angeles-Han, MD, MSc (she/her/hers) – Cincinnati Children's Hospital
    Abstract Moderator: Kathryn Torok, MD – University of Pittsburgh
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    2:00 PM - 2:10 PM PT
    2473: A Consensus Based Algorithm to Screen for Lung Disease in Children with Systemic Juvenile Idiopathic Arthritis
    Location: Room 7A-B
    Presenting Author: Holly Wobma, MD, PhD (she/her/hers) – Boston Children's Hospital
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    2:15 PM - 2:25 PM PT
    2474: Uveitis as Predictor of Disease Flare After the First Course of Anti-TNF Withdrawal in Oligo and Polyarticular Juvenile Idiopathic Arthritis: A Multicentric Italian Experience
    Location: Room 7A-B
    Presenting Author: Ilaria Maccora, MD (she/her/hers) – ​PhD student, in the Area of Drugs and Innovative Treatments, NeuroFARBA Department, University of Florence. Meyer Children's Hospital, Florence Italy
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    2:30 PM - 2:40 PM PT
    2475: Elevation of the IL-17 Cytokine Family Distinguishes Kawasaki Disease from Other Pediatric Inflammatory Disorders
    Location: Room 7A-B
    Presenting Author: Kailey Brodeur, BS – Boston Children's Hospital
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    2:45 PM - 2:55 PM PT
    2476: Defining Cutoffs for Disease Activity States in Systemic Juvenile Idiopathic Arthritis Based on the Systemic Juvenile Arthritis Disease Activity Score
    Location: Room 7A-B
    Presenting Author: Angelo Ravelli, MD – IRCCS Istituto Giannina Gaslini, Genoa, Italy
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    3:00 PM - 3:10 PM PT
    2477: Anifrolumab Normalizes the Type I Interferon Signature in a Cohort of Patients with Type I Interferonopathies
    Location: Room 7A-B
    Presenting Author: Sara Alehashemi, MD, MPH – NIH/NIAID/TADS
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Tuesday, Nov 14th
    3:15 PM - 3:25 PM PT
    2478: Effect of Conventional and Biologic Disease-Modifying Anti-Rheumatic Drugs on the Antibody Response to Four Doses of COVID-19 mRNA Vaccines in Children with Autoimmune and Rheumatic Diseases
    Location: Room 7A-B
    Presenting Author: Janna Shapiro, PhD, MSc – University of Toronto
    Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma